Latest Gross Margins News

SkinKandy posted a strong debut full year as a listed company, growing revenue to $90.2 million and net profit to $9 million, both ahead of Prospectus expectations, driven by aggressive store expansion and robust same-store sales.

Nanosonics reported steady FY26 revenue growth driven by its trophon disinfection platform and advanced the CORIS System towards commercial launch, backed by a strong balance sheet and a new $40 million share buyback.

SiteMinder Limited (ASX:SDR) nearly doubled its adjusted EBITDA to $28.1 million in FY26, driven by a 22% revenue increase and strong adoption of its AI-powered Smart Platform. The company narrowed its net loss by more than half amid ongoing investments in growth and operational efficiency.

EVZ Limited reported a 14% revenue increase to $123.1 million and a 213% jump in net profit after tax to $3.87 million for FY2026, resuming dividends for the first time since 2010.

MOVE Logistics Group has completed its strategic Reset phase, reporting a return to positive normalised earnings and improved cashflow in FY26, despite ongoing challenges in its warehousing division.

The Warehouse Group expects a sharp rebound in FY26 operating profit, projecting NZD 20 million to 24 million, up from just NZD 1.3 million last year, driven by margin gains at Noel Leeming and Warehouse Stationery amid subdued consumer spending.

Xenitra Limited has secured A$1.5 million through a discounted share placement to accelerate growth in higher-margin OTC medicines, FSMP, and tokenised FMCG sales. The capital will fund inventory expansion, supplier fulfilment, and ecommerce activation as the company shifts from low-margin distribution to a diversified healthcare platform.

Rubicon Water's FY26 results reveal an 11.6% revenue drop to $61.1 million and a net loss widening to $15.7 million, impacted by US federal funding delays and currency headwinds. Despite this, the company secured $28.4 million in second-half contracts and holds a $47 million major project pipeline, underpinning confidence for FY27 growth.

Kogan.com Ltd reversed a $39.5 million loss in FY25 to post an $11.2 million profit in FY26, driven by revenue growth, margin expansion, and a Mighty Ape turnaround. The group declared an 8 cent fully franked final dividend and maintained a strong cash position with no debt.

Adairs Limited delivered 3.8% sales growth in FY26, driven by strong performances at Adairs and Mocka, while Focus on Furniture faced a sharp earnings hit and a $63.5 million goodwill impairment. The group declared a 6.0 cent final dividend amid ongoing strategic transformation.

Ampol Limited reported a dramatic turnaround with a $1.36 billion statutory profit in H1 2026, buoyed by soaring refinery margins and the strategic acquisition of EG Australia.

Cyclopharm Limited posted a fifth consecutive record half-year revenue of $17.5 million, propelled by a 74% jump in US Technegas® sales and a doubling of revenue-generating US sites. New US clinical guidelines naming Technegas® as the preferred ventilation imaging agent underpin a robust growth outlook despite a wider net loss.